News ItemIN THE KNOW: July, 2020

July 27, 2020 – 


Important updates from NMBio

View this email in your browser

July 27, 2020

NEW MEXICO BIOTECHNOLOGY
& BIOMEDICAL ASSOCIATION

Dear Members & Prospective Members:


I’m delighted to finally have the opportunity and time to return to writing a monthly newsletter and to forward you a digital copy of New Mexico’s Bioscience Industry – Where The Biggest Problems Are Solved.  The 16-page insert in the July issue of Site Selection magazine showcases NM’s expanding bioscience sector and highlights eight firms that are on the verge of major success as well as the reasons why we are now in a position and are ready to compete with our neighboring and distant states for corporate relocations and expansions. Here is link to the report: https://siteselection.com/digitalEdition/2020/jul/#page=135
 
I spent the better part of two months raising $50,000-plus to showcase NM to a national audience and international audience of corporate executives, site location consultants, commercial brokers and real estate investors/developers as well as to write/edit the vast majority of the editorial. The article opens with quotes and insights from Alicia Keys, State Secretary of  Economic Development, Stuart Rose, serial entrepreneur and founder of The BioScience Center, and Steven Wray of Econsult Solutions. He recently oversaw the creation of a strategic plan for the NM Bioscience Authority.  Bottom line: these experts and others quoted in the article expect NM to have a true bioscience hub within the next five years. We’ll be distributing the insert to NM elected officials at the county, state and federal levels as well as to the state’s economic development organizations.
 
NMBio’s board members and I owe a tremendous thank you to the firms that financially supported this special initiative with ads, including the NM Bioscience Authority, the New Mexico Partnership, The City of Albuquerque, Albuquerque Economic Development, Arrowhead Park and the Mesilla Valley Economic Development Alliance, US Bank, AMRI Global and Colliers International. In addition, more than a dozen bioscience startups contributed to the creation of NMBio’s first ever ad (see page 137). We truly appreciated your enthusiastic support. When time permits, please send me your comments/reviews, including what we missed and what we should emphasize the next time an opportunity like this presents itself.  Also, please share the digital link with your colleagues and others that might have an interest in knowing more about the state’s bioscience sector.
 
While we are continually updated with Covid-19 news at the state and national levels, we are now starting to see and hear more political ads from President Trump and former Vice President Joe Biden. Mike Mattoon, VP of Federal Government Relations for BIO (he was one of our keynote speakers at January’s legislative luncheon event), sent us a link to the Biden Campaign policy recommendations in many areas.  Healthcare runs from page 28 to 37, drug pricing starts on page 32.  There are more specifics starting on page 89: https://joebiden.com/wp-content/uploads/2020/07/UNITY-TASK-FORCE-RECOMMENDATIONS.pdf
 
At the request of Albuquerque-based Charles Harb, I’m forwarding a link to a feasibility survey  —  http://tiny.cc/NM-TIME. that will help him determine the viability of developing “transitional incubator” that would help small and early stage firms that need ramping up space for their manufacturing operations. The typical client of this incubator is seen as one that has already done R&D and prototyping (perhaps in more traditional incubation or accelerator environments), needs to expand and streamline their manufacturing, but is not ready to incur the expenses of securing its own facility and equipment. Please feel free to contact Charles at charles.harb@ring-ir.com or 559-474-5256 if you have any questions or suggestions about this initiative or the survey.

Breaking news on NMBio members includes the selection of Julia Wise, Ph.D. as our newest board member. Julia works at the Feynman Center at Los Alamos National Labs. She previously served at the Director of Science and Technology for the NM Economic Development Department.
 
Michelle Miller of Innate Immunity has been selected to present at the prestigious White Hat conference this September. Prior members that have presented at this event include Simon Barriga of Vision Quest Biomedical and AVISA Pharma’s David Joseph. AVISA is going public on the Toronto Stock Exchange.

Member James F. Leary, President and Founder of Aurora Life Technologies,  reports that he’s put the finishing touches on a four year project and is now looking for new consulting/prototyping/invent-for-hire/research subcontract opportunities either here in New Mexico or anywhere in the world (his last major project was in Ireland).  He has expertise is in several areas including: (1) single-cell and rare-cell analysis by high-speed flow cytometry/cell sorting; (2) portable point-of-care devices for medical diagnostics or environmental monitoring, (3) bio-nano drug-delivery systems. Jim’s company has a well-equipped lab in the Santa Fe Business Incubator. He also has more than 35 years’ experience in successfully writing (and serving as reviewer) of SBIR’s for a number of Federal agencies. His scientific reputation can help add credibility to a client’s research proposals. His CV can be seen on LinkedIn, and is also available on his company website — http://auroralifetechnologies.com.
His email:  jfleary412@gmail.com.
 
I’ll also call your attention to BIO’s ninth biennial TEConomy/BIO report: The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities. The report focuses on the economic footprint of the bioscience industry for the nation, states, and metropolitan areas. The report includes four pages of individual fact sheets for all 50 states. An interactive map can be found hereMore »

Finally, I’ll call your attention to Boston-based Xconomy is the authoritative voice for the life sciences, focusing on funding, partnerships, and technologies supporting research and development of novel therapeutics. Its independent editorial team delivers the latest news and analysis on the financials and innovations driving startups as they move from discovery and development toward commercialization. Its business-to-business events, award shows, webinars, and whitepapers keep entrepreneurs, investors, and scientists relevant and informed – while facilitating deep, valuable connections and collaborations across the ecosystem. You can sign up for its newsletters here: Subscribe to Xconomy newsletters You can also access its special and free report on
 

Biopharma and Tech Innovators Summer 2020 to learn more about the cutting-edge companies behind these innovations that are disrupting the sector and revolutionizing the healthcare landscape. Read our new special report
 
Healthy regards,
 
Greg

 

Now Available! The Best of BIO

Free access to the best education sessions from the 2020 BIO Digital Week, hosted by the Biotechnology Innovation Organization. Hear the industry’s best tackle pressing topics including COVID-19, digital health, business development, oncology, gene editing, and the latest therapeutic advancements in biotech. Details 
Start: 
July 1 @ 8:00 am 
End: 
July 31 @ 5:00 pm 
Event Category:
home event
Website: 
https://www.bio.org/policy/human-health/vaccines-biodefense/coronavirus/bio-digital-sessions?wchannelid=7bm3dffscr

BioPharma Leaders Announce New Effort To Tackle Superbugs, Develop New Antiobotics

More than 20 leading biopharmaceutical companies announced yesterday the creation of an estimated $1 billion fund to help support the pipeline for new antibiotic treatments. The AMR Action Fund was launched as antimicrobial resistance, or AMR, continues to grow and take lives. In a statement, BIO President and CEO Dr. Michelle McMurry-Heath said, “Even as the world’s scientists work tirelessly to fight COVID-19, we must not ease up on our battle against antimicrobial resistance.”

Guide: How to Approach Life Sciences Funding

 

BREX, a Bio Business Solutions partner, has published a detailed and informative guide that explores the different sources of funding available to biotech startups and their relative merits, and how you should best utilize that funding at each stage of your research.

More Info »

Educational Training for Life Science Professionals

BIO Online Learning offers on-demand online courses to help professionals understand the science, business, and regulatory processes essential to the biotechnology, pharmaceutical, molecular diagnostics, and medical device industries. Browse dozens of online courses in a variety of industry areas including drug manufacturing, biotech basics, drug development, biosafety, and more. Discounts are available for NMBio members. Learn more.

 

SEARCHING FOR THE BEST WAY TO ENTER A NEW GLOBAL MARKET?
Understanding the export process, planning ahead, and identifying the best markets are the first steps a successful exporter takes. But how do you connect with buyers? How do you find interested distributors or partners? What about lucrative projects or trusted service providers? The U.S. Commercial Service can help you answer those tough questions. Start with the resources below and explore several sales channel options and virtual solutions for reaching prospective buyers. More »

SEEKING HEALTHCARE INNOVATIONS FOR THE NEW NORMAL
SUBMISSION DEADLINE: AUGUST 31, 2020 
Johnson & Johnson Innovation is launching the Seoul Innovation QuickFire Challenge for Healthcare in the New Normal to provide up to two innovators with the best ideas aiming to address and enable potential healthcare solutions in the post-COVID with $125,000 (approx.) in grant funding. More »

CONFERENCES:

VENTURE SUMMIT | VIRTUAL CONNECT GLOBAL
AUGUST 4 – 6
If you are a startup seeking early-stage funding, submit your plan for the opportunity to present at Venture Summit\Virtual Connect, the premier venue connecting venture-backed, emerging, and early-stage companies with more than 100 active venture capitalists, corporate VCs, angel investors, and investment firms. More »

White Hat Investors Conference 2020: September 15-16: https://www.azbio.org/white-hat-investors-2020

2020 BIO IMPACT Ag & Environment Conference, September 21-22
For 2020, BIO IMPACT Digital will transition to a comprehensive two-day virtual education and partnering event. This virtual gathering of the global agriculture and environment biotech industry will take place September 21-22 and deliver a critical business development, educational and networking experience for all attendees. REGISTER

 FIRST LOOK AT THE VIRTUAL MEDTECH CONFERENCE 2020 | TORONTO, ONTARIO 
ON DEMAND/PARTNERING: SEPTEMBER 8 – OCTOBER 23; LIVESTREAM: OCTOBER 5–9
The MedTech Conference is proud to bring you unparalleled programming opportunities every year, and this year is no exception. We’re sharing just a few of our sessions and networking opportunities that will be offered virtually in 2020. See what’s in store for this year and make plans to participate! More »
 

New Members:

Angelina Biomedical Laboratories (ABL, “able”) is coming to Santa Fe.  After 17 years at Los Alamos National Laboratory, ABL’s founder, Edwin H. Goodwin, moved to Colorado to start his first company, KromaTiD Inc., in Fort Collins.  Now on a mission to create genetic tests with the sensitivity and accuracy needed to detect cancer at an early stage, Dr. Goodwin is returning to New Mexico. He’s leasing space at the Santa Fe Business incubator.  “Impressive growth in the state’s bioscience sector, as well as the area’s artistic and cultural attractions, recreational opportunities, and culinary marvels, were persuasive factors in deciding to relocate to New Mexico,” he says.
 
GPER G-1, a portfolio company of the New Mexico Start-Up Factory, is developing a novel therapeutic for the treatment of diabetes and obesity. The company’s leading drug candidate for the treatment of obesity (through weight loss) and the treatment of diabetes and pre-diabetes (by restoring insulin sensitivity and glucose homeostasis) is Tespria™, the GPER agonist G-1. Dr. John Elling, the CEO of GPER G-1 Development Group, stated: “The company is making progress on developing a new compound that will significantly aid individuals with diabetes. Our compound, TespriaTM, has shown efficiency in mouse models and the molecule is currently being evaluated in human patients for another indication.” The National Institutes of Health (NIH) via the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded the GPER G-1 Development Group a STTR grant in the amount of $300,000 to support the project titled “Development of an innovative diabetes therapeutic via GPER targeting.” This grant will allow the company to extend tests carried out by UNM researchers, led by Dr. Eric Prossnitz, and perform pre-clinical pharmacokinetic and toxicity studies.
 
Innate Immunity is focused on plant and crop health. It aims to clear some of the most devastating bacterial, viral, and fungal diseases affecting cherished crops. The firm works to increase the host’s innate immunity to clear and resist disease. “We prevent pathogen-induced diseases with the design of host-derived antibacterial chimeras currently applied for the treatment of grape, citrus, apple, and pear – with other crops in our sights,” says Michelle Miller, PhD, co-founder and CTO.

Las Cruces-based Filtravate develops and commercializes ultrafiltration membranes for applications in the bioprocessing and biopharmaceutical industries. By building membranes from the ground up using the smallest building blocks, Filtravate’s membranes have controlled and tunable pore size, even pore distribution, and functionalized surfaces. Based on patent-pending technology exclusively licensed from New Mexico State University (NMSU), Filtravate’s products provide significant anti-fouling and improved flux characteristics. Yun Li, PhD is the CEO.
 

BIO Business Solutions Featured Service Provider for July


ShareVault is the only virtual data room provider with features specifically developed for life sciences applications, streamlining the review of regulatory submissions, eTMFs, accelerating due diligence, and utilizing bank-grade security. See how ShareVault’s security features compare to the competition. Discounts are offered to NMBio members. Learn more.  

Summer Reads:
Drug Giants Create Fund To Bolster Struggling Antibiotic Startups
https://www.bizjournals.com/albuquerque/news/2020/07/10/drug-giants-create-fund-to-bolster-struggling-anti.html?ana=e_ae_prem
 
A Guide To Investor Pitch Decks For Startup Fundraising:
https://www.forbes.com/sites/allbusiness/2020/06/20/guide-to-investor-pitch-decks-for-startup-fundraising/#6c46bb2e5a5a
 
14 Popular Crowdfunding Platforms: https://www.business2community.com/finance/14-popular-crowdfunding-platforms-02303841
 

Greg Byrnes
Executive Director
NMBio
610-731-3671 (M)

Connect with NMBio

          

 

 

Copyright © 2018 NMBio, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|* *|END:IF|*

Our mailing address is:
P.O. BOX 31516 Santa Fe, NM 87594

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list

*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*


 

Share:
Novo Norodisk

Novo Norodisk

Southwest Labs

Southwest Labs

UPS

UPS

AMRI

AMRI

Aerotek

Aerotek

Emera

Emera

Amgen

Amgen

STC UTM

STC UTM

Arrowhead Center

Arrowhead Center

New Mexico Consortium

New Mexico Consortium

Bio

Bio

Burrell College of Osteopathic Medicine

Burrell College of Osteopathic Medicine

Bristol Myers Squibb

Bristol Myers Squibb

Sandia National Laboratories

Sandia National Laboratories